Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Maternal & Public HealthAbortion Drugs Issues in Law & Medicine

Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019

Additional Authors: Benjamin D. Beran M.D.; Michael D. Lockwood D.O; Sigmund Seiler M.D.

ABSTRACT:

Objectives: Primary:

Analyze the Adverse Events (AEs) reported to the Food and Drug Administration (FDA) after use of mifepristone as an abortifacient.

Secondary:

Analyze maternal intent after ongoing pregnancy and investigate hemorrhage after mifepristone alone.

Methods:

Adverse Event Reports (AERs) for mifepristone used as an abortifacient, submitted to the FDA from September 2000 to February 2019, were analyzed using the National Cancer Institute’s Common Terminology Criteria for Adverse Events (CTCAEv3).

Results:

The FDA provided 6158 pages of AERs. Duplicates, non US, or AERs previously published (Gary, 2006) were excluded. Of the remaining, there were 3197 unique, US-only AERs of which there were 537 (16.80%) with insufficient information to determine clinical severity, leaving 2660 (83.20%) Codable US AERs (Figure 1). Of these, 20 were Deaths, 529 were Life-threatening, 1957 were Severe, 151 were Moderate, and 3 were Mild.

Read Complete Article

Latest Posts

July 20, 2026 A woman in a hospital gown is in labor, holding someone's hand for support while medical staff assist during childbirth, closely monitoring for any medical indications that might require separating mother and unborn child. Fact Sheet: Medical Indications for Separating a Mother and Her Unborn Child July 20, 2026 Abortion Reporting: Wyoming (2025) July 20, 2026 Abortion Reporting: South Dakota (2025)

You Might Also Be Interested In

A woman in a hospital gown is in labor, holding someone's hand for support while medical staff assist during childbirth, closely monitoring for any medical indications that might require separating mother and unborn child.

Fact Sheet: Medical Indications for Separating a Mother and Her Unborn Child

July 20, 2026
Please login to bookmark Close

Abortion Reporting: Wyoming (2025)

July 20, 2026
Please login to bookmark Close

Abortion Reporting: South Dakota (2025)

July 20, 2026
Please login to bookmark Close

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image